Overview

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer

Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
This study aims to investigate the feasibility, safety and efficacy of triplet regimen of neoadjuvant chemotherapy in patients with locally advanced rectal cancer
Phase:
Phase 2
Details
Lead Sponsor:
Aiping Zhou
Treatments:
Irinotecan
Oxaliplatin